Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Nifty Pharma Index Fund
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct) and ICICI Prudential Nifty Pharma Index Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Index Funds schemes — see the best index funds for the full ranking.
Head to head
NAVs as of 28 Sep 2026
Growth of ₹100 (rebased over the selected window)
Common period 15 Dec 2022 – 25 Sep 2026, limited by ICICI Prudential Nifty Pharma Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund | ICICI Prudential Nifty Pharma Index Fund | Nifty 500 |
|---|---|---|---|
| 15 Dec 2022 | ₹100.00 | ₹100.00 | ₹100.00 |
| 09 Apr 2023 | ₹95.48 | ₹95.98 | ₹93.51 |
| 02 Aug 2023 | ₹111.70 | ₹116.49 | ₹106.81 |
| 25 Nov 2023 | ₹117.35 | ₹123.91 | ₹111.78 |
| 19 Mar 2024 | ₹132.96 | ₹142.91 | ₹124.24 |
| 12 Jul 2024 | ₹147.84 | ₹159.66 | ₹146.32 |
| 04 Nov 2024 | ₹158.90 | ₹175.43 | ₹142.67 |
| 27 Feb 2025 | ₹150.98 | ₹156.82 | ₹128.71 |
| 22 Jun 2025 | ₹154.52 | ₹167.64 | ₹145.98 |
| 15 Oct 2025 | ₹163.54 | ₹171.57 | ₹148.11 |
| 07 Feb 2026 | ₹167.20 | ₹170.87 | ₹148.47 |
| 02 Jun 2026 | ₹173.77 | ₹186.62 | ₹142.68 |
| 25 Sep 2026 | ₹197.15 | ₹210.32 | ₹143.21 |
Portfolio overlap (same stocks held through more than one fund)
Some overlap is structural: SEBI defines large cap as the top 100 stocks by market capitalisation, so two large-cap funds are fishing the same pond by regulation. The bands below are measured per sleeve pairing rather than against one blanket threshold. How this is measured →
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund and ICICI Prudential Nifty Pharma Index Fund duplicate 52% of their equity book — holding both adds concentration, not diversification.
Shared holdings — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Nifty Pharma Index Fund
| Stock | Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund | ICICI Prudential Nifty Pharma Index Fund | |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.00% | 20.78% | 11.00% |
| Divi's Laboratories Ltd. | 6.97% | 11.89% | 6.97% |
| Torrent Pharmaceuticals Ltd. | 4.45% | 7.34% | 4.45% |
| Cipla Ltd. | 4.38% | 7.84% | 4.38% |
| Laurus Labs Ltd. | 4.14% | 7.36% | 4.14% |
| Dr. Reddy's Laboratories Ltd. | 3.56% | 6.96% | 3.56% |
| Lupin Ltd. | 3.08% | 5.25% | 3.08% |
| Aurobindo Pharma Ltd. | 2.76% | 4.70% | 2.76% |
| Glenmark Pharmaceuticals Ltd. | 2.15% | 3.69% | 2.15% |
| IPCA Laboratories Ltd. | 1.70% | 2.71% | 1.70% |
| Biocon Ltd. | 1.64% | 2.91% | 1.64% |
| Mankind Pharma Ltd. | 1.54% | 2.71% | 1.54% |
| Alkem Laboratories Ltd. | 1.37% | 3.08% | 1.37% |
| Zydus Lifesciences Ltd. | 1.33% | 2.87% | 1.33% |
| Gland Pharma Ltd. | 1.32% | 2.27% | 1.32% |
1 more stocks in common. 16 shared of 44 / 20 positions. Weights are shown as a share of each fund's equity book.
| Metric | Edelweiss · Direct NAV ₹25.00 Very High risk ★★★★★ | ICICI Prudential · Direct NAV ₹20.72 Very High risk ★★★★★ | Category median Index Funds · 383 funds |
|---|---|---|---|
| +24.27% | +24.44%Best in row | +3.94% | |
| +20.51% | +20.88%Best in row | +7.41% | |
| +14.27% | — | +6.17% | |
| +16.83% | +21.41%Best in row | +7.10% | |
| +18.65% | +19.76%Best in row | — | |
| +17.75% | +22.20%Best in row | +12.49% | |
| +14.17% | — | +13.28% | |
| Risk | |||
| 11.58%Best in row | 15.05% | 13.75% | |
| 1.21Best in row | 0.96 | 0.03 | |
| 1.74Best in row | 1.38 | 0.03 | |
| -16.31%Best in row | -16.59% | -16.10% | |
| — | Nifty 500 | — | |
| — | +11.30% | +0.43% | |
| — | 0.66 | 1.01 | |
| — | 109.3% | 102.2% | |
| — | 52.8% | 99.6% | |
| 0.55% | 0.51%Best in row | 0.36% | |
| — | ₹121.63Cr | ₹181.49Cr | |
| ₹100 | ₹1.00K | — | |
| — | ₹1.00K | — | |
| — | 30% | 31% | |
| Bhavesh Jain | Ashwini Shinde | — | |
| 02 Nov 2020 | 15 Dec 2022 | — | |
| 44 | 20 | — | |
| 55.2% | 78.8% | — | |
5 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Exit load
- None
- Lock-in
- None
- Cash & equivalents
- 0.1%
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Over the last 3 years, ICICI Prudential Nifty Pharma Index Fund returned +20.88% CAGR against Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund's +20.51%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has the lower expense ratio: Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund charges 0.55% a year against ICICI Prudential Nifty Pharma Index Fund's 0.51%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has shown higher volatility (+15.05% annualized vs Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund's +11.58%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund -12.15% vs ICICI Prudential Nifty Pharma Index Fund -16.59%.
Are Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund and ICICI Prudential Nifty Pharma Index Fund in the same category?
Yes — both are Index Funds schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.